Department of Surgical Sciences, Umberto I University Hospital, La Sapienza, Rome, Italy.
Emergency Surgery, St. Orsola University Hospital, Alma Mater Studiorum, c/o Policlinico Sant'Orsola-Malpighi Via Massarenti, 9, Bologna, Italy.
Updates Surg. 2021 Oct;73(5):1767-1774. doi: 10.1007/s13304-021-00994-9. Epub 2021 Feb 13.
The risk of developing hemorrhagic complications during or after emergency cholecystectomy (EC) for acute cholecystitis (AC) in patients with antithrombotic therapy (ATT) remains uncertain. In this double-center study, we evaluated post-operative outcomes in patients with ATT undergoing EC. We retrospectively evaluated 538 patients who underwent laparoscopic EC for AC between May 2015 and December 2019 at two referral centers. 89 of them (17%) were on ATT. We defined postoperative complication rates, including bleeding, as our primary outcome. Mortality was higher in the ATT group. Morbidity was higher in the ATT group as well; however, the difference was not statistically significant. 12 patients (2%) experienced intraoperative blood loss over 500 ml and ten (2%) had postoperative bleeding complications. Two patients (< 1%) experienced both intraoperative and postoperative bleeding. On multivariate analysis, ATT was not significantly associated with worse postoperative outcomes. Antithrombotic therapy is not an independently associated factor of severe postoperative complications (including bleeding) or mortality. However, these patients still represent a challenging group and must be carefully managed to avoid postoperative bleeding complications.
在接受抗血栓治疗 (ATT) 的患者中,行急诊胆囊切除术 (EC) 治疗急性胆囊炎 (AC) 期间或之后发生出血并发症的风险仍不确定。在这项双中心研究中,我们评估了接受 EC 的 ATT 患者的术后结局。我们回顾性评估了 2015 年 5 月至 2019 年 12 月在两个转诊中心接受腹腔镜 EC 治疗的 538 例 AC 患者,其中 89 例(17%)正在接受 ATT。我们将术后并发症发生率(包括出血)定义为主要结局。ATT 组的死亡率更高。ATT 组的发病率也更高;然而,差异无统计学意义。12 名患者(2%)术中出血量超过 500ml,10 名患者(2%)发生术后出血并发症。2 名患者(<1%)同时发生术中及术后出血。多变量分析显示,ATT 与术后不良结局无显著相关性。抗血栓治疗并不是严重术后并发症(包括出血)或死亡率的独立相关因素。然而,这些患者仍然是一个具有挑战性的群体,必须谨慎管理以避免术后出血并发症。